无抗生素的响应生物材料用于特定的和有针对性的Helicobacter pylori根除
Yating Zheng1, Tinglin Zhang2, Juan Shao3
1Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China; Yangzhou Branch of Jiangsu Provincial Corps of Chinese People's Armed Police Force, Yangzhou 225007, Jiangsu, China.
概括
新型无抗生素响应的生物材料提供向根除Helicobacter pylori (H. pylori),克服耐药性和保护肠道微生物群. 这种创新方法解决了胃癌预防的关键挑战.
科学领域:
- 生物材料科学 生物材料科学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 胃癌与Helicobacter pylori感染密切相关,影响全球50%的人口.
- 目前的H. pylori治疗面临重大障碍,包括抗生素耐药性和肠道微生物群的破坏.
- 迫切需要综合性治疗,尽量减少对肠道菌群的负面影响,以预防胃癌.
研究的目的:
- 审查用于根除H. pylori的非抗生素响应生物材料的最新进展.
- 探索这些生物材料以各种形式 (浮游生物,生物膜,细胞内) 抗击H. pylori的机制.
- 讨论针对H. pylori消除和未来临床转换的策略.
主要方法:
- 对针对H. pylori的响应性生物材料的最新研究的总结.
- 对抗H. pylori机制的分析,包括对抗浮游生物细菌,生物膜和细胞内细菌的机制.
- 针对性消除策略和临床应用挑战的讨论.
主要成果:
- 响应的生物材料显示出特定的H.pylori根除的潜力.
- 这些材料可以通过各种刺激 (pH,酶,光,超声波,磁性) 激活,以获得针对性的抗菌作用.
- 这种方法避免了肠道微生物群的广泛破坏,与传统的抗生素不同.
结论:
- 无抗生素响应的生物材料为消除H. pylori提供了一种创新的策略.
- 这些生物材料的向消除为传统疗法提供了一个有希望的替代方案,可以缓解耐药性和微生物群问题.
- 需要进一步的研究来应对成功临床翻译的挑战.
更多相关视频
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
323
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
323
01:26Peptic Ulcer Disease IV: Management
66
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
66
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
86
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
86
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
349
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
349
00:57Antibiotic Selection
52.2K
Overview
52.2K
01:23Gastritis III: Clinical Manifestations and Management
135
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
135